Latest News

Add to Favorites Subscribe Share
newswise-fb-share-
Newswise: MITRE Unveils Laboratory Focused on Autonomous Technology

MITRE Unveils Laboratory Focused on Autonomous Technology

MITRE

In MITRE's Mobile Autonomous Systems Experimentation (MASE) Laboratory, team are researching ways to accelerate advanced autonomous technology and provide objective perspective and recommendations for broad impact in multiple domains, including drones, commercial aircraft, tanks, and self-driving vehicles.

Channels: Automotive, Engineering, Entrepreneurship, Technology, Travel and Transportation,

Released:
16-Jan-2020 2:00 PM EST
Newswise: Cancer study may accidentally help researchers create usable blood stem cells

Cancer study may accidentally help researchers create usable blood stem cells

University of Colorado Cancer Center

University of Colorado Cancer Center study shows healthy form of the leukemia-causing gene MLL may push pluripotent stem cells (which have proven difficult to use in human patients) to become durable hematopoietic stem cells (which are usable in patients, but have until now been impossible to make).

Channels: All Journal News, Blood, Cancer, Cell Biology, Stem Cells, Grant Funded News,

Released:
16-Jan-2020 2:00 PM EST
Feature
Newswise: Mobile protected areas needed to protect biodiversity in the high seas
  • Embargo expired:
    16-Jan-2020 2:00 PM EST

Mobile protected areas needed to protect biodiversity in the high seas

University of Washington

In this week's issue of Science, marine scientists make the case for the United Nations to include mobile marine protected areas in the U.N. Convention on the Law of the Sea, or UNCLOS, now being updated since its last signing in 1982.

Channels: Climate Science, Environmental Science, Marine Science, Nature, All Journal News,

Released:
15-Jan-2020 7:05 PM EST
Research Results
  • Embargo expired:
    16-Jan-2020 2:00 PM EST

Mosquitoes Engineered to Repel Dengue Virus

University of California San Diego

An international team of scientists has synthetically engineered mosquitoes that halt the transmission of the dengue virus. The development marks the first engineered approach in mosquitoes that targets the four known types of dengue, improving upon previous designs that addressed single strains.

Channels: Children's Health, Engineering, Immunology, Zika Virus, Southeast Asia News, PLOS ONE, All Journal News,

Released:
13-Jan-2020 2:55 PM EST
Research Results
Newswise: Engineered Mosquitoes Cannot Be Infected with or Transmit Any Dengue Virus
  • Embargo expired:
    16-Jan-2020 2:00 PM EST

Engineered Mosquitoes Cannot Be Infected with or Transmit Any Dengue Virus

PLOS

Genetically engineered mosquitoes are resistant to multiple types of dengue virus (DENV), according to a study published January 16 in the open-access journal PLOS Pathogens by Prasad Paradkar of the Australian Animal Health Laboratory, and Omar Akbari of the University of California, San Diego, and colleagues. As noted by the authors, this is the first engineered approach that targets all types of DENV, which is crucial for effective disease suppression.

Channels: Cell Biology, Genetics, Infectious Diseases, Public Health, Staff Picks, PLOS ONE, All Journal News,

Released:
9-Jan-2020 4:05 PM EST
Research Results
Newswise: John Theurer Cancer Center Participating in Early-Phase Study of Immunotherapy-Boosting Treatment

John Theurer Cancer Center Participating in Early-Phase Study of Immunotherapy-Boosting Treatment

Hackensack Meridian Health

Investigators at John Theurer Cancer Center at Hackensack University Medical Center in New Jersey are participating in a first-in-patients clinical trial assessing VE800, a novel bacteria-containing therapy, in combination with the immunotherapy drug nivolumab. Laboratory research has suggested that VE800 may enhance the effectiveness of drugs like nivolumab.

Channels: Cancer, Digestive Disorders, Immunology, Liver Disease, Microbiome, OBGYN,

Released:
16-Jan-2020 1:55 PM EST
Research Results
Newswise: Hackensack University Medical Center First Hospital in New Jersey to Perform Kidney Transplant Using Cutting-Edge, Life-Saving Technology

Hackensack University Medical Center First Hospital in New Jersey to Perform Kidney Transplant Using Cutting-Edge, Life-Saving Technology

Hackensack Meridian Health

Hackensack Meridian Hackensack University Medical Center today announced that it became the first hospital in the New Jersey to perform a kidney transplant with a kidney preserved at its own Organ Preservation Center using the LifePort Kidney Transporter, an ex vivo hypothermic machine preservation technology. Hypothermic machine preservation is a cutting-edge, life-saving technology that increases a kidney’s viability and lifespan, improving patient outcomes.

Channels: Kidney Disease, Surgery, Transplantation,

Released:
16-Jan-2020 1:50 PM EST
Feature
Newswise: Untreated Sleep Apnea Puts Heart Health at Risk

Untreated Sleep Apnea Puts Heart Health at Risk

American Academy of Sleep Medicine (AASM)

With February’s focus on American Heart Month, people should be aware that sleep apnea impacts heart health. The American Academy of Sleep Medicine warns that obstructive sleep apnea affects nearly 30 million Americans, and it can lead to serious cardiovascular consequences.

Channels: Cardiovascular Health, Heart Disease, Sleep,

Released:
16-Jan-2020 1:50 PM EST
Feature
Newswise: Hackensack University Medical Center Participated in Nationwide Study that Finds Three Medications are Safe and Effective in Treating Life-Threatening Seizures

Hackensack University Medical Center Participated in Nationwide Study that Finds Three Medications are Safe and Effective in Treating Life-Threatening Seizures

Hackensack Meridian Health

Hackensack University Medical Center researchers in Emergency Medicine participated in a nationwide study published in the New England Journal of Medicine in November 2019 that concluded that three drugs are equally safe and effective in treating patients with life-threatening seizures called Status Epilepticus (SE). The new study, Established Status Epilepticus Treatment Trial (ESETT), examined three medications commonly administered in the emergency department to treat SE – levetiracetam, fosphenytoin, and valproate – in order to learn which is most effective in treating patients.

Channels: All Journal News, Neuro, NEJM,

Released:
16-Jan-2020 1:50 PM EST
Feature
Newswise: The Center for Dentistry at Hackensack University Medical Center to Offer Free Dental Care through “Give Kids a Smile” Program

The Center for Dentistry at Hackensack University Medical Center to Offer Free Dental Care through “Give Kids a Smile” Program

Hackensack Meridian Health

The Center for Dentistry at Hackensack University Medical Center will be participating in the American Dental Association’s “Give Kids a Smile” program on Friday, February 7. Free preventive and restorative dental care will be offered to children ages 12 and younger by appointment only from 9:00am to 4:00pm at the Hillcrest Building, 60 Second Street, Hackensack.

Channels: Children's Health, Oral Health,

Released:
16-Jan-2020 1:50 PM EST
Research Results


0.74672